BRAZIL - 2020/08/26: In this photo illustration the Teva Pharmaceutical Industries logo seen ... [+] displayed on a smartphone. (Photo Illustration by Rafael Henrique/SOPA Images/LightRocket via Getty Images) SOPA Images/LightRocket via Getty Images Going by historical performance, Teva Pharmaceuticals stock (NYSE: TEVA) could offer upside of over 40% from the current levels. Our conclusion is based on our detailed analysis comparing Teva’s stock performance during the current crisis with that during the 2008 recession in an interactive dashboard analysis. That said, in the case of Teva, attractive valuation could well be a trap, as we discuss below. TEVA stock trades at $9 currently and it is down 4% so far this year. It is also down 30% from the pre-Covid high of $13 seen ...read more...